This research represents a novel exploration into the MRGs of SLE, identifying FAM210B, MSRB2, LYRM7, IFI27, and SCO2 as significant candidates for classifying and therapeutic targeting. This evidence concerns the gene LYRM7 and systemic lupus erythematosus.